These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15365215

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.
    de Leeuw AS, Westenberg HG.
    J Psychiatr Res; 2008 Sep; 42(11):894-901. PubMed ID: 18533183
    [Abstract] [Full Text] [Related]

  • 3. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation.
    Goodman WK, McDougle CJ, Price LH, Barr LC, Hills OF, Caplik JF, Charney DS, Heninger GR.
    Biol Psychiatry; 1995 Aug 01; 38(3):138-49. PubMed ID: 7578657
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
    Khanna S, John JP, Reddy LP.
    Psychoneuroendocrinology; 2001 Feb 01; 26(2):209-23. PubMed ID: 11087965
    [Abstract] [Full Text] [Related]

  • 7. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR.
    Arch Gen Psychiatry; 1988 Feb 01; 45(2):177-85. PubMed ID: 3337615
    [Abstract] [Full Text] [Related]

  • 8. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa.
    Hadigan CM, Walsh BT, Buttinger C, Hollander E.
    Biol Psychiatry; 1995 Apr 15; 37(8):504-11. PubMed ID: 7619973
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL.
    Biol Psychiatry; 1991 Mar 01; 29(5):418-26. PubMed ID: 2018816
    [Abstract] [Full Text] [Related]

  • 11. Serotonin-1D hypothesis of obsessive-compulsive disorder: an update.
    Zohar J, Kennedy JL, Hollander E, Koran LM.
    J Clin Psychiatry; 2004 Mar 01; 65 Suppl 14():18-21. PubMed ID: 15554784
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.
    Arch Gen Psychiatry; 1992 Jan 01; 49(1):21-8. PubMed ID: 1728249
    [Abstract] [Full Text] [Related]

  • 15. The serotonin hypothesis of obsessive compulsive disorder.
    Barr LC, Goodman WK, Price LH.
    Int Clin Psychopharmacol; 1993 Nov 01; 8 Suppl 2():79-82. PubMed ID: 8201248
    [Abstract] [Full Text] [Related]

  • 16. Low versus standard dose mCPP challenge in obsessive-compulsive patients.
    Erzegovesi S, Martucci L, Henin M, Bellodi L.
    Neuropsychopharmacology; 2001 Jan 01; 24(1):31-6. PubMed ID: 11106873
    [Abstract] [Full Text] [Related]

  • 17. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects.
    Hollander E, Kwon J, Weiller F, Cohen L, Stein DJ, DeCaria C, Liebowitz M, Simeon D.
    Psychiatry Res; 1998 Jul 13; 79(3):213-7. PubMed ID: 9704868
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological challenge with a serotonin 1D agonist in alcohol dependence.
    Vythilingum B, Hugo CJ, Maritz JS, Pienaar W, Stein DJ.
    BMC Psychiatry; 2005 Aug 24; 5():31. PubMed ID: 16120224
    [Abstract] [Full Text] [Related]

  • 19. Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents.
    Ghaziuddin N, Welch K, Greden J.
    Neuropsychopharmacology; 2003 Jan 24; 28(1):133-9. PubMed ID: 12496949
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.